European shares close at fresh record high as Novo Nordisk drives healthcare boost
Euro zone equity volatility at over a year-low Healthcare stocks top gainers after Novo Nordisk boost Basic resources…
Medicare enrollees to pay 50% less for some drugs in 2025, report says
AARP study looks at first 10 drugs negotiated under IRA Finds 7 of the drugs will cost under…
Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs
DEC 15 (Reuters) – A federal judicial panel said Monday it would centralize a growing number of lawsuits…
FDA approves BioCryst’s oral pellet version of swelling disorder drug for children
Dec 12 (Reuters) – The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst…
US FDA approves first at-home device for depression
Dec 11 (Reuters) – The U.S. Food and Drug Administration has approved Flow Neuroscience’s at-home brain stimulation device…
UK pledges extra $2 billion NHS spend to avert Trump tariffs, FT says
Dec 11 (Reuters) – Britain has promised the United States that spending on National Health Service (NHS) medicines…
UK medicine rebate rate to drop in 2026 after US pharma deal
Item 1 of 2 Unused and expired medications, including pills, tablets and capsules, collected for disposal to prevent…
US FDA qualifies first AI tool to help speed liver disease drug development
Dec 8 (Reuters) – The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed…
AI’s rise stirs excitement, sparks job worries
AI’s impact on job growth and work transformation discussed at Reuters NEXT Concerns over AI’s role in job…
Data supports current US policy of hepatitis B vaccine for newborns, as officials push for change
CHICAGO, Dec 2 (Reuters) – An independent review released on Tuesday by vaccine experts of more than 400…
Bird flu virus could risk pandemic worse than COVID if it mutates, France’s Institut Pasteur says
People lack antibodies against bird flu, respiratory infections professor says Bird flu could affect healthy individuals, including children,…
Undeterred by Novo Nordisk failure, scientists consider GLP-1s as Alzheimer’s prevention
More trials needed testing the drugs in people at risk of dementia, scientists say Diabetes patients on GLP-1s…